Craig L. Slutzkin
PersonMentions
3
Relationships
2
Events
2
Documents
1
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
Event Timeline
Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
2 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
New Leaf
|
Employment |
6
|
1 | |
|
organization
Sprout
|
Former employment |
6
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2002-08-01 | N/A | Craig Slutzkin joined Sprout as Vice President and head of back office operations. | New York | View |
| 2002-08-01 | N/A | Craig Slutzkin joined Sprout as Vice President. | Unknown | View |
HOUSE_OVERSIGHT_024026.jpg
This document is page 15 of a confidential corporate report or prospectus for an entity named "New Leaf" (likely New Leaf Venture Partners). It profiles Craig L. Slutzkin, the Chief Financial Officer, detailing his background at Sprout, Arthur Andersen, and Ernst & Young. The document also outlines the firm's strategy regarding Industry Advisors, specifically noting they use a broad network for Therapeutics rather than a formal board, while maintaining a specific advisory board for Information Convergence. The document bears a House Oversight stamp.
Corporate profile / investment fund prospectus
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity